Guided Multi-objective Generative AI to Enhance Structure-based Drug Design

• URL: http://arxiv.org/abs/2405.11785v2
• Date: Thu, 17 Oct 2024 17:00:37 GMT
• Title: Guided Multi-objective Generative AI to Enhance Structure-based Drug Design
• Authors: Amit Kadan, Kevin Ryczko, Erika Lloyd, Adrian Roitberg, Takeshi Yamazaki,
• Abstract summary: We describe IDOLpro, a generative chemistry AI combining diffusion with multi-objective optimization for structure-based drug design. IDOLpro produces with binding affinities over 10%-20% better than the next best state-of-the-art method on each test set. We show that IDOLpro can generate molecules for a range of important disease-related targets with better binding affinity and synthetic accessibility than any molecule found in the virtual screen.
• Score: 0.0
• License:
• Abstract: Generative AI has the potential to revolutionize drug discovery. Yet, despite recent advances in deep learning, existing models cannot generate molecules that satisfy all desired physicochemical properties. Herein, we describe IDOLpro, a generative chemistry AI combining diffusion with multi-objective optimization for structure-based drug design. Differentiable scoring functions guide the latent variables of the diffusion model to explore uncharted chemical space and generate novel ligands in silico, optimizing a plurality of target physicochemical properties. We demonstrate our platform's effectiveness by generating ligands with optimized binding affinity and synthetic accessibility on two benchmark sets. IDOLpro produces ligands with binding affinities over 10%-20% better than the next best state-of-the-art method on each test set, producing more drug-like molecules with generally better synthetic accessibility scores than other methods. We do a head-to-head comparison of IDOLpro against a classic virtual screen of a large database of drug-like molecules. We show that IDOLpro can generate molecules for a range of important disease-related targets with better binding affinity and synthetic accessibility than any molecule found in the virtual screen while being over 100x faster and less expensive to run. On a test set of experimental complexes, IDOLpro is the first to produce molecules with better binding affinities than experimentally observed ligands. IDOLpro can accommodate other scoring functions (e.g. ADME-Tox) to accelerate hit-finding, hit-to-lead, and lead optimization for drug discovery.

Related papers

• BatGPT-Chem: A Foundation Large Model For Retrosynthesis Prediction [65.93303145891628]
  BatGPT-Chem is a large language model with 15 billion parameters, tailored for enhanced retrosynthesis prediction. Our model captures a broad spectrum of chemical knowledge, enabling precise prediction of reaction conditions. This development empowers chemists to adeptly address novel compounds, potentially expediting the innovation cycle in drug manufacturing and materials science.
  arXiv  Detail & Related papers  (2024-08-19T05:17:40Z)
• Aligning Target-Aware Molecule Diffusion Models with Exact Energy Optimization [147.7899503829411]
  AliDiff is a novel framework to align pretrained target diffusion models with preferred functional properties. It can generate molecules with state-of-the-art binding energies with up to -7.07 Avg. Vina Score.
  arXiv  Detail & Related papers  (2024-07-01T06:10:29Z)
• Latent Chemical Space Searching for Plug-in Multi-objective Molecule Generation [9.442146563809953]
  We develop a versatile 'plug-in' molecular generation model that incorporates objectives related to target affinity, drug-likeness, and synthesizability. We identify PSO-ENP as the optimal variant for multi-objective molecular generation and optimization.
  arXiv  Detail & Related papers  (2024-04-10T02:37:24Z)
• DecompDiff: Diffusion Models with Decomposed Priors for Structure-Based Drug Design [62.68420322996345]
  Existing structured-based drug design methods treat all ligand atoms equally. We propose a new diffusion model, DecompDiff, with decomposed priors over arms and scaffold. Our approach achieves state-of-the-art performance in generating high-affinity molecules.
  arXiv  Detail & Related papers  (2024-02-26T05:21:21Z)
• Diffusing on Two Levels and Optimizing for Multiple Properties: A Novel Approach to Generating Molecules with Desirable Properties [33.2976176283611]
  We present a novel approach to generating molecules with desirable properties, which expands the diffusion model framework with multiple innovative designs. To get desirable molecular fragments, we develop a novel electronic effect based fragmentation method. We show that the molecules generated by our proposed method have better validity, uniqueness, novelty, Fr'echet ChemNet Distance (FCD), QED, and PlogP than those generated by current SOTA models.
  arXiv  Detail & Related papers  (2023-10-05T11:43:21Z)
• Multi-objective Molecular Optimization for Opioid Use Disorder Treatment Using Generative Network Complex [5.33208055504216]
  Opioid Use Disorder (OUD) has emerged as a significant global health issue. In this study, we propose a deep generative model that combines a differential equation (SDE)-based diffusion modeling with the latent space of a pretrained autoencoder model. The molecular generator enables efficient generation of molecules that are effective on multiple targets.
  arXiv  Detail & Related papers  (2023-06-13T01:12:31Z)
• Molecular Fingerprints for Robust and Efficient ML-Driven Molecular Generation [0.0]
  We propose a novel molecular fingerprint-based variational autoencoder applied for molecular generation on real-world drug molecules. We observe a substantial improvement in chemical synthetic accessibility ($DeltabarSAS$ = -0.83) and in computational efficiency up to 5.9x in comparison to an existing state-of-the-art SMILES-based architecture.
  arXiv  Detail & Related papers  (2022-11-16T18:07:43Z)
• LIMO: Latent Inceptionism for Targeted Molecule Generation [14.391216237573369]
  We present Latent Inceptionism on Molecules (LIMO), which significantly accelerates molecule generation with an inceptionism-like technique. Comprehensive experiments show that LIMO performs competitively on benchmark tasks. One of our generated drug-like compounds has a predicted $K_D$ of $6 cdot 10-14$ M against the human estrogen receptor.
  arXiv  Detail & Related papers  (2022-06-17T21:05:58Z)
• Exploring Chemical Space with Score-based Out-of-distribution Generation [57.15855198512551]
  We propose a score-based diffusion scheme that incorporates out-of-distribution control in the generative differential equation (SDE) Since some novel molecules may not meet the basic requirements of real-world drugs, MOOD performs conditional generation by utilizing the gradients from a property predictor. We experimentally validate that MOOD is able to explore the chemical space beyond the training distribution, generating molecules that outscore ones found with existing methods, and even the top 0.01% of the original training pool.
  arXiv  Detail & Related papers  (2022-06-06T06:17:11Z)
• Molecular Attributes Transfer from Non-Parallel Data [57.010952598634944]
  We formulate molecular optimization as a style transfer problem and present a novel generative model that could automatically learn internal differences between two groups of non-parallel data. Experiments on two molecular optimization tasks, toxicity modification and synthesizability improvement, demonstrate that our model significantly outperforms several state-of-the-art methods.
  arXiv  Detail & Related papers  (2021-11-30T06:10:22Z)
• MIMOSA: Multi-constraint Molecule Sampling for Molecule Optimization [51.00815310242277]
  generative models and reinforcement learning approaches made initial success, but still face difficulties in simultaneously optimizing multiple drug properties. We propose the MultI-constraint MOlecule SAmpling (MIMOSA) approach, a sampling framework to use input molecule as an initial guess and sample molecules from the target distribution.
  arXiv  Detail & Related papers  (2020-10-05T20:18:42Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.